| 30/10/24 | 07:00:08 | 30 Oct 2024 | | R&D Spotlight focusing on pipeline advances | RNS |
| 28/10/24 | 07:00:06 | 28 Oct 2024 | | Block Listing Six Monthly Return | RNS |
| 24/10/24 | 07:00:08 | 24 Oct 2024 | | Avacta Reports Pipeline Avances at EORTC | RNS |
| 21/10/24 | 16:00:00 | 21 Oct 2024 | | Issue of Equity and Total Voting Rights | RNS |
| 21/10/24 | 07:00:04 | 21 Oct 2024 | | Avacta and Tempus Enter Strategic Collaboration | RNS |
| 17/10/24 | 07:00:05 | 17 Oct 2024 | | Avacta Expands its Pipeline | RNS |
| 15/10/24 | 07:00:06 | 15 Oct 2024 | | Avacta appoints Chief Scientific Officer | RNS |
| 10/10/24 | 07:00:05 | 10 Oct 2024 | | Avacta Unveils Pipeline Expansion at EORTC 2024 | RNS |
| 30/09/24 | 07:00:13 | 30 Sept 2024 | | Interim Results | RNS |
| 16/09/24 | 07:00:07 | 16 Sept 2024 | | Avacta Reported Updated Phase 1 Data of AVA6000 | RNS |
| 12/09/24 | 07:00:13 | 12 Sept 2024 | | Notice of Results | RNS |
| 09/09/24 | 07:00:07 | 9 Sept 2024 | | Avacta to present clinical data at ESMO Congress | RNS |
| 02/09/24 | 15:53:56 | 2 Sept 2024 | | Director/PDMR Shareholdings and TVR | RNS |
| 18/07/24 | 07:00:10 | 18 Jul 2024 | | Convertible Bond Payment | RNS |
| 26/06/24 | 14:46:25 | 26 Jun 2024 | | Result of AGM | RNS |
| 26/06/24 | 07:00:12 | 26 Jun 2024 | | AGM Business Update | RNS |
| 20/06/24 | 07:00:10 | 20 Jun 2024 | | Shaun Chilton appointed Non-Executive Chairman | RNS |
| 11/06/24 | 07:00:10 | 11 Jun 2024 | | Appointment of Nominated Adviser and Sole Broker | RNS |
| 31/05/24 | 07:00:13 | 31 May 2024 | | Posting of Annual Report and Notice of AGM | RNS |
| 23/05/24 | 07:00:13 | 23 May 2024 | | Successful Completion of First Cohort | RNS |
| 30/04/24 | 07:01:00 | 30 Apr 2024 | | Full Year Results | RNS |
| 30/04/24 | 07:00:15 | 30 Apr 2024 | | Board Change | RNS |
| 26/04/24 | 09:51:57 | 26 Apr 2024 | | Block listing Interim Return REPLACEMENT | RNS |
| 26/04/24 | 07:00:12 | 26 Apr 2024 | | Block Listing Six Monthly Return | RNS |
| 23/04/24 | 09:43:05 | 23 Apr 2024 | | Block Listing Application to AIM | RNS |
| 23/04/24 | 07:00:10 | 23 Apr 2024 | | Notice of Results | RNS |
| 22/04/24 | 12:14:55 | 22 Apr 2024 | | Issue of Equity and Total Voting Rights | RNS |
| 09/04/24 | 17:00:00 | 9 Apr 2024 | | Avacta Reports Data at the AACR Annual Meeting | RNS |
| 08/04/24 | 07:00:07 | 8 Apr 2024 | | AVA6000 Abstract Release by AACR | RNS |
| 28/03/24 | 16:00:35 | 28 Mar 2024 | | Investor Webinar | RNS |
| 21/03/24 | 07:00:06 | 21 Mar 2024 | | Update on AVA6000 Phase 1a Clinical Trial Progress | RNS |
| 18/03/24 | 13:26:28 | 18 Mar 2024 | | Result of General Meeting | RNS |
| 06/03/24 | 07:00:09 | 6 Mar 2024 | | Avacta Announces AVA6000 Poster at AACR | RNS |
| 05/03/24 | 07:00:10 | 5 Mar 2024 | | Result of REX Retail Offer | RNS |
| 29/02/24 | 07:00:13 | 29 Feb 2024 | | Result of Placing | RNS |
| 28/02/24 | 16:42:19 | 28 Feb 2024 | | Proposed REX Retail Offer | RNS |
| 28/02/24 | 16:41:25 | 28 Feb 2024 | | Proposed Fundraise to progress Therapeutics | RNS |
| 16/02/24 | 07:00:06 | 16 Feb 2024 | | Share Incentive Plan/Issue of Equity | RNS |
| 22/01/24 | 10:51:02 | 22 Jan 2024 | | Issue of Equity and Total Voting Rights | RNS |
| 19/01/24 | 07:00:03 | 19 Jan 2024 | | Appointment of Christina Coughlin | RNS |
| 19/12/23 | 07:00:11 | 19 Dec 2023 | | Appointment of Chief Business Officer | RNS |
| 13/12/23 | 07:00:16 | 13 Dec 2023 | | ALS-6000-101 Phase 1a Study Data | RNS |
| 04/12/23 | 07:00:04 | 4 Dec 2023 | | Shareholder update to review AVA6000 Phase 1a data | RNS |
| 27/10/23 | 07:00:10 | 27 Oct 2023 | | Block Listing Six Monthly Return | RNS |
| 23/10/23 | 13:30:00 | 23 Oct 2023 | | Issue of Equity and Total Voting Rights | RNS |
| 18/10/23 | 13:00:00 | 18 Oct 2023 | | Block Listing Application to AIM | RNS |
| 05/10/23 | 07:00:03 | 5 Oct 2023 | | Avacta to present at AACR-NCI-EORTC conference | RNS |
| 29/09/23 | 13:30:02 | 29 Sept 2023 | | Director/PDMR Shareholding | RNS |
| 28/09/23 | 07:00:09 | 28 Sept 2023 | | Interim Results for the Period Ending 30 June 2023 | RNS |
| 20/09/23 | 14:00:01 | 20 Sept 2023 | | Issue of Equity and Total Voting Rights | RNS |
